Cree Reports Financial Results for the Fourth Quarter and Fiscal Year 2015

Go back to Cree Reports Financial Results for the Fourth Quarter and Fiscal Year 2015

UBS Cuts Price Target on Cree (CREE) Following Sep-15 and FY16 Guidance

August 12, 2015 9:49 AM EDT

UBS maintained a Neutral rating on Cree (NASDAQ: CREE), and cut the price target to $28.00 (from $30.50), following its Sep-15 and FY16 guidance. Cree guided Sep-15 quarterly sales and EPS to $420M and $0.21 which was in line with consensus. FY16 guidance was unchanged, except for FCF which was... More

Cree (CREE) Tops Q4 EPS by 23c, Offers Q1 Guidance

August 11, 2015 4:03 PM EDT

Cree (NASDAQ: CREE) reported Q4 EPS of $0.19, $0.23 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $382 million versus the consensus estimate of $378.92 million.

Cree sees Q1 2015 EPS of $0.18-$0.23, versus the consensus of $0.20. Cree sees Q1 2015 revenue of $410-430... More